Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.


We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time (SMRT™) technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform the understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.

Events & Presentations

Pacific Biosciences of California, Inc. Second Quarter 2017 Earnings Conference Call

Aug 2, 2017 at 4:30 PM ET

Read More »

Pacific Biosciences of California, Inc. First Quarter 2017 Earnings Conference Call

Apr 26, 2017 at 4:30 PM ET

Read More »

Pacific Biosciences of California, Inc. Fourth Quarter 2016 Earnings

Feb 2, 2017 at 1:30 PM PT

Read More »

2017 JP Morgan Healthcare Conference

Jan 8, 2017
Westin St. Francis
San Francisco

Read More »

Recent News

Stock Quote

NASDAQ (GM): PACB
Price $4.13
Last Trade 4:00 PM ET
Aug 18, 2017
Change $0.00
Change (%) 0.000%
Volume N/A
52 Week High N/A
52 Week Low N/A
Day High N/A
Day Low N/A
Delayed at least 20 minutes.

Investor
Contact

Pacific Biosciences

1305 O’Brien Drive

Menlo Park, CA  94025

ir@pacb.com